Company · CIK 0001510487 · SIC 2834 — Pharmaceutical Preparations
Principia Biopharma Inc. · PRNB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2018 PForm 4 → | Sep 20, 7:02 pm EDT | Sofinnova Venture Partners VIII, L.P. +410% Owner | 270,000 | $17.00 | $4,590,000 | 2,038,208 | +15.3% | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 7:02 pm EDT | Sofinnova Venture Partners VIII, L.P. +410% Owner | 1,768,208 | — | — | 1,768,208 | — | plan? |
| Sep 18, 2018 PForm 4 → | Sep 20, 6:59 pm EDT | ORBIMED ADVISORS LLC +110% Owner | 250,000 | $17.00 | $4,250,000 | 2,605,713 | +10.6% | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:59 pm EDT | ORBIMED ADVISORS LLC +110% Owner | 2,355,713 | — | — | 2,355,713 | — | plan? |
| Sep 18, 2018 PForm 4 → | Sep 20, 6:58 pm EDT | Daniel J. BeckerDirector, 10% Owner | 270,000 | $17.00 | $4,590,000 | 437,537 | +161% | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:58 pm EDT | Daniel J. BeckerDirector, 10% Owner | 2,355,713 | — | — | 167,537 | — | plan? |
| Sep 18, 2018 PForm 4 → | Sep 20, 6:53 pm EDT | New Leaf Ventures II, L.P. +510% Owner | 270,000 | $17.00 | $4,590,000 | 437,537 | +161% | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:53 pm EDT | New Leaf Ventures II, L.P. +510% Owner | 2,355,713 | — | — | 167,537 | — | plan? |
| Sep 18, 2018 PForm 4 → | Sep 20, 6:50 pm EDT | Simeon GeorgeDirector, 10% Owner | 270,000 | $17.00 | $4,590,000 | 2,625,713 | +11.5% | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:50 pm EDT | Simeon GeorgeDirector, 10% Owner | 2,355,713 | — | — | 2,355,713 | — | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:47 pm EDT | Steve GourlayChief Medical Officer | 7,269 | — | — | 107,857 | — | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:45 pm EDT | Martin BablerChief Executive Officer, Director | 3,684 | — | — | 6,732 | — | plan? |
| Sep 18, 2018 PForm 4 → | Sep 20, 5:18 pm EDT | GLAXOSMITHKLINE PLC10% Owner | 270,000 | $17.00 | $4,590,000 | 2,625,713 | +11.5% | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 5:18 pm EDT | GLAXOSMITHKLINE PLC10% Owner | 2,355,713 | — | — | 2,355,713 | — | plan? |
| Sep 18, 2018 PForm 4 → | Sep 20, 4:14 pm EDT | Srinivas AkkarajuDirector | 175,000 | $17.00 | $2,975,000 | 383,480 | +83.9% | plan? |
| Sep 18, 2018 CForm 4 → | Sep 20, 4:14 pm EDT | Srinivas AkkarajuDirector | 208,480 | — | — | 208,480 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 AForm 4 → | Mar 8, 5:42 pm EST | Stefani WolffChief Development Officer | 60,000 | — | — | 60,000 | — | late |
| Mar 1, 2019 AForm 4 → | Mar 8, 5:40 pm EST | Dolca ThomasChief Medical Officer | 60,000 | — | — | 60,000 | — | late |
| Mar 1, 2019 AForm 4 → | Mar 8, 5:38 pm EST | David GoldsteinChief Scientific Officer | 60,000 | — | — | 60,000 | — | late |
| Mar 1, 2019 AForm 4 → | Mar 8, 5:35 pm EST | Roy C. HardimanChief Business Officer | 60,000 | — | — | 60,000 | — | late |
| Mar 1, 2019 AForm 4 → | Mar 8, 5:33 pm EST | Christopher Y ChaiChief Financial Officer | 60,000 | — | — | 60,000 | — | late |
| Mar 1, 2019 AForm 4 → | Mar 8, 5:31 pm EST | Martin BablerChief Executive Officer, Director | 155,000 | — | — | 155,000 | — | late |
| Feb 19, 2019 AForm 4 → | Feb 21, 6:07 pm EST | John W SmitherDirector | 20,475 | — | — | 20,475 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 7:02 pm EDT | Sofinnova Venture Partners VIII, L.P. +410% Owner | 1,768,208 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:59 pm EDT | ORBIMED ADVISORS LLC +110% Owner | 2,355,713 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:58 pm EDT | Daniel J. BeckerDirector, 10% Owner | 2,355,713 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:53 pm EDT | New Leaf Ventures II, L.P. +510% Owner | 2,355,713 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:50 pm EDT | Simeon GeorgeDirector, 10% Owner | 2,355,713 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:47 pm EDT | Steve GourlayChief Medical Officer | 7,269 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 6:45 pm EDT | Martin BablerChief Executive Officer, Director | 3,684 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 5:18 pm EDT | GLAXOSMITHKLINE PLC10% Owner | 21,399,081 | — | — | 0 | — | |
| Sep 18, 2018 CForm 4 → | Sep 20, 4:14 pm EDT | Srinivas AkkarajuDirector | 208,480 | — | — | 0 | — | |
| Sep 13, 2018 AForm 4 → | Jan 15, 2019, 4:57 pm EST | GLAXOSMITHKLINE PLC10% Owner | 20,475 | — | — | 20,475 | — | late |
| Sep 13, 2018 AForm 4 → | Jan 10, 2019, 9:53 pm EST | Lewis ShusterDirector | 20,475 | — | — | 20,475 | — | late |
| Sep 13, 2018 AForm 4 → | Jan 10, 2019, 9:48 pm EST | Simeon GeorgeDirector, 10% Owner | 20,475 | — | — | 20,475 | — | late |
| Sep 13, 2018 AForm 4 → | Jan 10, 2019, 9:47 pm EST | Alan ColowickDirector | 20,475 | — | — | 20,475 | — | late |
| Sep 13, 2018 AForm 4 → | Jan 10, 2019, 9:43 pm EST | Daniel J. BeckerDirector, 10% Owner | 20,475 | — | — | 20,475 | — | late |
| Sep 13, 2018 AForm 4 → | Jan 10, 2019, 9:40 pm EST | Srinivas AkkarajuDirector | 20,475 | — | — | 20,475 | — | late |